Study Evaluating Safety and Efficacy of UCART123v1.2 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT03190278 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03190278
- Sponsor
- Cellectis S.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-19
- Primary completion
- 2024-12-24
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.